Market Introduction
The cell line can be defined as as cell culture, wherein the cells multiply by adapting in growing medium and space for growth. The cell line development serum market growth is mainly attributed to the serum as a source of growth and adhesion factors, lipids, hormones, and minerals for cells' culture in basal media. The serum serves as a carrier for enzymes, micronutrients, lipids, and trace elements into the cell and also regulates cell membrane permeability.
Market Overview and Dynamics
The South and Central America cell line development serum market is expected to reach US$ 103.49 Mn in 2027 from US$ 68.38 Mn in 2019. The market is estimated to grow with a CAGR of 5.3% from 2020 to 2027. Key factors that are driving growth of the South and Central America cell line development serum market are increasing adoption of regenerative medicines, rising prevalence of cancer across the globe and increasing investments in R&D by pharmaceutical and biotechnology companies.
Key Market Segments
Based on type, the South and Central America cell line development serum market is segmented into fetal bovine serum, porcine serum, adult bovine serum, horse serum, and other animal serum. The fetal bovine serum segment held a significant share of the market and is estimated to register the highest CAGR during the forecast period.
Based on application, the South and Central America cell line development serum market is segmented into tissue engineering and regenerative medicines, academic research, drug discovery, toxicity testing, and bioproduction. In 2019, the bioproduction segment held the largest share of the market; whereas, the drug discovery segment is anticipated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
Some of the primary and secondary sources associated with this report on the South and Central America cell line development serum market are International Association for Stem Cell Application (ISSCA); Brazilian Association of Cell Therapy (ABTCell); American Type Culture Collection (ATCC); and World Health Organization (WHO); among others.
Reasons to buy the report
SOUTH AND CENTRAL AMERICA CELL LINE DEVELOPMENT SERUM MARKET SEGMENTATION
By Type
By Country
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 68.38 Million |
| Market Size by 2027 | US$ 103.49 Million |
| CAGR (2020 - 2027) | 5.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South and Central America Cell Line Development Serum Market is valued at US$ 68.38 Million in 2019, it is projected to reach US$ 103.49 Million by 2027.
As per our report South and Central America Cell Line Development Serum Market, the market size is valued at US$ 68.38 Million in 2019, projecting it to reach US$ 103.49 Million by 2027. This translates to a CAGR of approximately 5.3% during the forecast period.
The South and Central America Cell Line Development Serum Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Cell Line Development Serum Market report:
The South and Central America Cell Line Development Serum Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Cell Line Development Serum Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Cell Line Development Serum Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)